Oral Steroids

Drostanolone 25 mg Biotech Beijing

Biotech Beijing

70,00

In Stock (100 available)

Drostanolone 25 mg Biotech Beijing (25 mg) — When the goal is maximum visual impact — razor-sharp definition, paper-thin skin, and roadmap vascularity — Drostanolone is th…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Drostanolone (Masteron), Biotech Beijing, 25 mg. DHT-class anti-estrogenic anabolic with minimal side-effect burden relative to its visual impact. Low-bodyfat cutting staple; Propionate for EOD schedules, Enanthate for 2×-weekly flexibility.

Key Benefits

  • DHT-derivative — dry, hard, vascular look with no water retention
  • Anti-estrogenic side-activity — mild AI effect
  • Cutting and pre-contest staple, especially at low body-fat
  • Minimal sides at performance doses — clean compound
  • Stacks well with tren, test, and orals for cutting recomp
  • Each unit dosed at 25 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: propionate 300–500 mg/week split EOD or 3×/week; enanthate 400–600 mg/week split twice weekly. Cycles 8–10 weeks (prop) or 10–14 weeks (eno). Pre-contest protocols stretch to final 6 weeks before show.

How It Works

5α-reduced testosterone with a 2α-methyl group. DHT-derivative — does not aromatise. Mild anti-estrogenic activity via aromatase enzyme competition. High AR affinity. Androgenic but not aggressively so at typical doses.

Pharmacokinetics

Propionate ester: plasma half-life ~2 days. Enanthate: ~7 days. Prop needs EOD or M/W/F pinning; eno twice-weekly fine. Steady-state in 2 weeks (prop) or 4 weeks (eno).

Cycle & Stacking Guide

Cutting stack component, 8–14 weeks by ester. Classic pairing: test E 250 mg/week + masteron E 400 mg/week + (optional) tren or winstrol for final weeks. Works best at <15% body fat where the "dry" look actually shows.

Manufacturer Notes

Biotech Beijing is a Chinese producer with a long track record in both AAS and peptide markets. HPLC purity data available for peptide SKUs.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Drostanolone 25 mg Biotech Beijing”

Your email address will not be published. Required fields are marked *

Drostanolone Propionate

Physical & Chemical Properties for Research Purposes
Chemical structure of Drostanolone Propionate (C23H36O3) for laboratory analysis
2D structural representation · PubChem CID 224004 ↗
Chemical Identity
# CAS Registry Number 521-12-0
Σ IUPAC Name [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate
F Molecular Formula C23H36O3
M Molecular Weight 360.53 g/mol
SMILES CCC(=O)O[C@@H]1CC[C@@H]2[C@H]3CC[C@@H]4CC(=O)[C@@H](C)C[C@]4(C)[C@@H]3CC[C@]12C
InChIKey VDIINQKPRNWKEH-GOGNSEEVSA-N
Melting Point 124-126 °C
Solubility Insoluble in water; soluble in oils
Biological Half-life 2.5 days (IM)
PubChem CID 224004 ↗
Pharmacological Profile
Anabolic Rating 62
Androgenic Rating 25
Aromatization None
Hepatotoxicity None
Detection Time 3 weeks

Clinical Notes

DHT-derived injectable — 2alpha-methyl modification at the A-ring confers resistance to 3alpha-HSD, allowing intact muscle-cell activity. Cannot aromatise. Weak AR binding in skeletal tissue but displaces estradiol from SHBG, increasing free-testosterone fraction of any concurrent testosterone — this is the mechanism behind the hardening clinical picture at low body-fat percentages. Effect is visibly null above 15% body fat; below 12%, the lean-tissue definition response becomes dose-responsive. Propionate ester mandates EOD injection schedule; PIP is common and dose-dependent — low-viscosity MCT or GSO carrier oil reduces it materially. Androgenic effects (scalp, prostate) occur but are limited to DHT-sensitive populations.

Known trade names: Masteron, Drostopro, Mastabol

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.